Wed, Aug 20, 2014, 7:19 PM EDT - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

Nymox Pharmaceutical Corporation Message Board

  • NEWMOX NEWMOX Oct 20, 2011 12:27 PM Flag

    Growing market

    Datamonitor expects to see an increase in the number of histologic benign prostatic hyperplasia (BPH) cases between 2010 and 2020 in the seven major markets (the US, Japan, France, Germany, Italy, Spain, and the UK). The number of total BPH cases is expected to increase from approximately 79.1 million cases in 2010 to 92.4 million cases in 2020.

    Datamonitor expects to see an increase in the number of symptomatic benign prostatic hyperplasia (BPH) cases between 2010 and 2020 in the seven major markets. The number of symptomatic BPH cases is expected to increase from around 38.9 million cases in 2010 to 45.8 million cases in 2020.

    The largest increase in the number of BPH cases is expected in the US for both total and symptomatic BPH. Between 2010 and 2020, the number of total prevalent cases of BPH will increase by 2.2% annually and the number of symptomatic BPH cases will increase by 2.4% annually.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
 
NYMX
5.19-0.01(-0.19%)Aug 20 3:59 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.